[
    [
        {
            "time": "2018-09-22",
            "original_text": "格隆汇港股聚焦(9.22)︱中通快递在港上市发行价厘定为218港元；建设银行拟发行不超1600亿元二级资本工具",
            "features": {
                "keywords": [
                    "中通快递",
                    "上市",
                    "发行价",
                    "建设银行",
                    "二级资本工具"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "物流",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(9.22)︱中通快递在港上市发行价厘定为218港元；建设银行拟发行不超1600亿元二级资本工具",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-22",
            "original_text": "智通港股公告精选|(9.22)乐享互动公开发售超购逾千倍 再鼎医药招股定价562港元",
            "features": {
                "keywords": [
                    "乐享互动",
                    "超购",
                    "再鼎医药",
                    "招股定价"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智通港股公告精选|(9.22)乐享互动公开发售超购逾千倍 再鼎医药招股定价562港元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-22",
            "original_text": "晚间公告热点追踪：快手直播“一哥”入股 步步股份四连板",
            "features": {
                "keywords": [
                    "快手",
                    "入股",
                    "步步股份",
                    "连板"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "互联网",
                    "传媒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "晚间公告热点追踪：快手直播“一哥”入股 步步股份四连板",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-22",
            "original_text": "晚间公告热点追踪：三妖股异常交易账户被立案调查 50亿参与搏杀",
            "features": {
                "keywords": [
                    "妖股",
                    "异常交易",
                    "立案调查",
                    "搏杀"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "市场投机"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "晚间公告热点追踪：三妖股异常交易账户被立案调查 50亿参与搏杀",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-23",
            "original_text": "A股头条之上市公司（9.23）",
            "features": {
                "keywords": [
                    "A股",
                    "上市公司"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "A股头条之上市公司（9.23）",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-22",
            "original_text": "精彩来袭|第五届中华医学事务年会之国内药企专场",
            "features": {
                "keywords": [
                    "中华医学事务年会",
                    "药企"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "精彩来袭|第五届中华医学事务年会之国内药企专场",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-22",
            "original_text": "国际多中心临床试验提速 康希诺生物新冠候选疫苗会否后来居上？",
            "features": {
                "keywords": [
                    "康希诺生物",
                    "新冠疫苗",
                    "临床试验"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国际多中心临床试验提速 康希诺生物新冠候选疫苗会否后来居上？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-22",
            "original_text": "上海医药：瑞舒伐他汀钙片获药品注册证书",
            "features": {
                "keywords": [
                    "上海医药",
                    "瑞舒伐他汀钙片",
                    "药品注册证书"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药：瑞舒伐他汀钙片获药品注册证书",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]